Literature DB >> 15433723

Prostatic cancer; further investigation of hormonal relationships.

H BRENDLER, W E CHASE, W W SCOTT.   

Abstract

Entities:  

Keywords:  PROSTATE

Mesh:

Year:  1950        PMID: 15433723

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0272-5533


× No keyword cloud information.
  13 in total

1.  Hormonal control of neoplastic growth.

Authors:  R W RAWSON
Journal:  Bull N Y Acad Med       Date:  1953-08

2.  Recent advances in treatment of inoperable cancer.

Authors:  L F CRAVER
Journal:  Bull N Y Acad Med       Date:  1952-06

Review 3.  Differing levels of testosterone and the prostate: a physiological interplay.

Authors:  S Larry Goldenberg; Anthony Koupparis; Michael E Robinson
Journal:  Nat Rev Urol       Date:  2011-05-31       Impact factor: 14.432

4.  Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.

Authors:  Michael T Schweizer; Emmanuel S Antonarakis; Hao Wang; A Seun Ajiboye; Avery Spitz; Haiyi Cao; Jun Luo; Michael C Haffner; Srinivasan Yegnasubramanian; Michael A Carducci; Mario A Eisenberger; John T Isaacs; Samuel R Denmeade
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

Review 5.  The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.

Authors:  Michael W Drazer; Walter M Stadler
Journal:  Cancer J       Date:  2016 Sep/Oct       Impact factor: 3.360

6.  Androgen therapy in advanced carcinoma of the prostate.

Authors:  A Morales; J G Connolly; A W Bruce
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

7.  Bipolar Androgen Therapy: A Paradoxical Approach for the Treatment of Castration-resistant Prostate Cancer.

Authors:  Michael T Schweizer; Emmanuel S Antonarakis; Samuel R Denmeade
Journal:  Eur Urol       Date:  2017-03-29       Impact factor: 20.096

8.  Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator.

Authors:  P Geck; M V Maffini; J Szelei; C Sonnenschein; A M Soto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

9.  Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer.

Authors:  Samuel R Denmeade; John T Isaacs
Journal:  Prostate       Date:  2010-10-01       Impact factor: 4.104

10.  Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.

Authors:  D A Wolf; P Schulz; F Fittler
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.